Western Union Continues to Connect Communities and Economies at a Critical Time
Western Union (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today released its second annual Environmental, Social and Governance (ESG) Report, which spotlights the Company’s 2019 ESG progress. The report also highlights Western Union’s response and ongoing initiatives surrounding the COVID-19 pandemic and social justice movements across the globe in early 2020.
“Today, against the backdrop of COVID-19 and global protests against social injustice, business’s role in building a more united future has never seemed more relevant – or more urgent. Serving our stakeholders in today’s world takes determination and innovation. It demands that we build unity through ingenuity to create new, lasting solutions for people, businesses, and societies,” said Hikmet Ersek, President and CEO, Western Union. “This report provides an update on Western Union’s ESG efforts, and how we are addressing some of the most pressing global issues facing society, our shared environment, and our Company.”
The report highlights six key areas where Western Union is making an impact globally:
Connecting people and businesses to the global economy: Our services connect people and businesses pursuing global opportunities – for example, individuals looking to better the lives of their families, and businesses looking for new partners, customers, and markets. The transactions we process build bridges across economies, geographies, and cultures.
- In response to COVID-19, Western Union doubled down on its commitment to serve customers with a range of new offerings and resources including piloting home delivery of money transfers, introducing “digital location” concierge services to offer personalized phone or video support to help customers make digital money transfers, expanding westernunion.com to five additional countries bringing the total to more than 75, and expanding real-time account and wallet payout to 50 countries.
Fostering an engaging and inclusive workplace: Western Union works to build and support a workforce that reflects the global diversity of the 150 million customers we serve in more than 200 countries and territories around the world. It starts at the most senior levels of our business and manifests itself throughout our Board of Directors and our global workforce. We are actively engaging in open and honest dialogue with our employees and we are committed to playing a role in the fight for positive change globally. 2019 highlights include:
- Reaching gender parity with our customers and employees: approximately half of our customers and half of our global workforce are women.
- Our executive team in 2019 was comprised of 40% women and includes leaders born in 10 different countries who have wide-ranging global leadership experience.
Moving money with integrity: We are committed to using the right combination of people and technology to protect our customers and partners, keep illicit activity out of our network, and ensure we conduct our business with integrity.
- In 2019, we prevented $1.1 billion in fraudulent transactions. Overall industry data suggests a growing rate of fraudulent activity. Western Union’s fraud levels, however, are trending downward.
- Our Financial Intelligence Unit continues to partner with law enforcement and nonprofit entities to better target and disrupt human trafficking financial flows. This team has conducted approximately 1,800 human trafficking investigations since 2013, resulting in hundreds of arrests and the rescue of hundreds of victims.
Governing and managing for success: Western Union’s governance structures and practices provide oversight and guidance around critical issues, including ethics, board diversity, executive compensation, fair competition, data privacy, and cybersecurity, and board diversity. 2019 highlights include:
- Our Board is comprised of a wide range of nationalities from around the world.
- Three of our 11 Board members were women.
Safeguarding our shared environment: We are committed to acting responsibly to respect the environment and minimize our footprint.
- 25% of building materials, by value, are made of recycled materials at our global headquarters.
- We have equipped our major offices with state-of-the-art video conferencing technology, which reduced the need for air travel between locations, even prior to COVID-19.
Catalyzing change through the Western Union Foundation: The Western Union Foundation works to provide vulnerable youth with the skills needed to succeed in today’s global digital economy, and to support people across the globe through humanitarian relief.
- In 2019, the Western Union Foundation launched Opportunity Beyond Borders, a three-year and $15-million commitment to provide vulnerable youth with the skills and training needed to succeed in today’s global digital economy.
- As the impact of COVID-19 spread across the globe, Western Union and the Western Union Foundation announced a global matching challenge, with a total commitment of $1.3 million in customer, corporate, employee, and agent donations towards the global fight against the virus.
The Western Union 2019 ESG Report is available at: http://ir.westernunion.com/investor-relations/ESG/default.aspx. It is prepared in accordance with the Global Reporting Initiative (GRI) standards, and also includes responses to select relevant metrics from the Sustainability Accounting Standards Board (SASB) Standards.
WU-G
About Western Union
The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Our omnichannel platform connects the digital and physical worlds and makes it possible for consumers and businesses to send and receive money and make payments with speed, ease, and reliability. As of March 31, 2020, our network included over 550,000 retail agent locations offering our branded services in more than 200 countries and territories, with the capability to send money to billions of accounts. Additionally, westernunion.com, our fastest growing channel in 2019, is available in over 75 countries, plus additional territories, to move money around the world. With our global reach, Western Union moves money for better, connecting family, friends, and businesses to enable financial inclusion and support economic growth. For more information, visit www.westernunion.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200625005415/en/
Contact information
Western Union Contacts
Investor Relations:
Brendan Metrano; Brendan.metrano@wu.com
+1(720) 332-8089
Media Relations:
Western Union Global Communications
Rachel Rogala; Rachel.Rogala@wu.com
+ 1 (303) 808-2674
Pia De Lima; Pia.DeLima@wu.com
+1 (954) 260-5732
Western Union Americas
Margaret Fogarty; Margaret.Fogarty@wu.com
Western Union Middle East & Africa
Mohamed El Khalouki; Mohamed.ElKhalouki@wu.com
Western Union Asia-Pacific
Karen Santos; Karen.Santos2@wu.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 09:03:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 08:02:00 EEST | Press release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine28.4.2025 08:00:00 EEST | Press release
Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region. Pridopidine, a potent and highly selective, orally administered sigma-1 receptor agonist, designed to regulate key neuroprotective mechanisms that are often impaired in neurodegenerative diseases, is a promising candidate for the treatment of Huntington’s Disease (HD), a rare inherited neurodegenerative disease, with a high unmet medical need1. It has been studied in more than 1,700 people and long-term safety data of up to 7 years duration are available from previou
Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease27.4.2025 12:36:00 EEST | Press release
Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients. About FDA Designations The Rare Pediatric Disease Designation (RPDD) incentivizes therapies for serious or life-threatening diseases affecting fewer than 200,000 U.S. patients, primarily those aged 18 or younger. Sponsors may qualify for a Priority Review Voucher (PRV) upon approval to expedite FDA review of a subsequent drug application. The Orphan Drug Designation (ODD) supports therapies targeting rare diseases (affecting fewer than 200,000 U.S. patients) by provi
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom